AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Diagnosis of Tuberculosis in Swiss Children

Recruitingn/aAges any - 17 YearsAllUniversity Children's Hospital Basel
💬

In plain words

What the trial is, and whether it could suit you

1. The primary objective is to improve the sensitivity of novel immunodiagnostic tests for detection of TB disease in children. 2. The secondary objective is to determine biomarkers that discriminate children with TB infection and disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * all children / adolescents \< 18 years of age undergoing evaluation for TB exposure, infection or disease. Exclusion Criteria: * children / adolescents with TB infection or disease who have already been started on anti-mycobacterial treatment, children who have been treated for TB previously.
💊

What it tests

  • Secreted cytokine assay
  • Intracellular cytokine assay
📍

Where

8 sites
Kantonspital Aarau
Aarau, Switzerland
Nina Vaezipour
Basel, Switzerland
Ospedale Regionale di Bellinzona
Bellinzona, Switzerland
Inselspital Bern
Bern, Switzerland
Hôpital des enfants - HUG
Geneva, Switzerland
Kinserspital Luzern
Lucerne, Switzerland
Kinderspital St Gallen
Sankt Gallen, Switzerland
Kinderklinik Zürich
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy